InvestorsObserver
×
News Home

Savara Inc (SVRA) is down -16.10% in a Week, Should You Accumulate?

Thursday, March 14, 2024 12:48 PM | InvestorsObserver Analysts

Mentioned in this article

Savara Inc (SVRA) is down -16.10% in a Week, Should You Accumulate?

Savara Inc (SVRA) is around the top of the Biotechnology industry according to InvestorsObserver. SVRA received an overall rating of 77, which means that it scores higher than 77 percent of all stocks. Savara Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 77
SVRA has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on SVRA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Savara Inc Stock Today?

Savara Inc (SVRA) stock is trading at $4.69 as of 12:47 PM on Thursday, Mar 14, a decline of -$0.20, or -4.09% from the previous closing price of $4.89. The stock has traded between $4.68 and $4.89 so far today. Volume today is low. So far 262,275 shares have traded compared to average volume of 922,750 shares. Click Here to get the full Stock Report for Savara Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App